Our results also showed that Baicalein inhibits pancreatic cancer progression through inactivation of the PI3K/Akt and MEK/ERK signalings, which has been found to be highly active in pancreatic cancers [26]. This evidence concerns the gene MAP2K7 and pancreatic neoplasm.